Revolutionary Contributions of Emil von Behring and Shibasaburo Kitasato in Medicine and Microbiology: A Nobel Prize Story

Emil von Behring / Shibasaburo Kitasato

_____ discovered that serum of animals immune to diptheria/tetanus could provide short-lived protection against the effects of diptheria and tetanus. Utilization of antiserum for immunity proved to be a short-lived solution.

Emil von Behring and Shibasaburo Kitasato were both scientists who made significant contributions to the field of medicine and microbiology.

Emil von Behring, a German physiologist, is best known for his work on serum therapy, particularly for his development of an effective vaccine against diphtheria. He discovered that the blood serum of animals that had recovered from a particular disease contained protective substances that could be used to treat other individuals suffering from the same disease. Behring’s discovery of serum therapy revolutionized the treatment of infectious diseases and saved countless lives.

Shibasaburo Kitasato was a Japanese physician and microbiologist who worked with Emil von Behring in developing antitoxins for diphtheria and tetanus. He was also responsible for discovering the cause of bubonic plague, which led to the development of effective treatments for the disease. Kitasato’s work led to the development of various immunological and serological techniques, such as the isolation of bacterial toxins and the use of antiseptics.

Both Behring and Kitasato were awarded the Nobel Prize in Physiology or Medicine, Behring in 1901 and Kitasato in 1946. Their contributions to the field of medicine and microbiology continue to influence the development of treatments for infectious diseases.

More Answers:

Antigens: Their Role in Immune Responses, Disease Diagnosis, and Vaccine Development.
Ilya Metchnikov: Discovering Phagocytosis, Gut Microbiome and Advancing Immunology & Microbiology
Discovering the Foundations of Immunology: The Legacy of Paul Ehrlich

Error 403 The request cannot be completed because you have exceeded your quota. : quotaExceeded

Share:

Recent Posts